Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-015786

Director sold 4,720 shares at $2.97 ($14,018)

  • Director acquired 24,720 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Russell Angus C. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-29 Exercise or conversion : show line 1 in the form +24,720 $2.20 $54,384 92,220 D
2021-06-29 Sale : show line 2 in the form −4,720 $2.97 $14,018 87,500 D
Open-market sales · 4,720 sh · avg $2.97 · $14,018

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-29 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −24,720 0 D
Loading xslF345X03/ownership.xml…